BTS
CKPT

BB&T Securities’s Checkpoint Therapeutics CKPT Stock Holding History

BB&T Securities’s Portfolio CKPT Stock Details CKPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q3 		$25K Buy
+1,000
New +$27.4K ﹤0.01% 1605

Other funds holding CKPT

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $72.6B AUM 54.88% 1-Year Est. Return
OPPM
Opus Point Partners Management New York $55.3M AUM 7.48% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Nuveen
Nuveen Charlotte, North Carolina $419B AUM 43.02% 1-Year Est. Return
Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

BB&T Securities's CKPT Position: Q3 2019 in Review

BB&T Securities opened a new position in Checkpoint Therapeutics (CKPT) in Q3 2019: 1,000 shares worth $25K. The stake represents ﹤0.01% of the portfolio and ranks #1605 among its holdings.

37 funds tracked by Wall St. Rank hold CKPT as of Q3 2019.

  • BB&T Securities held 1,000 shares of Checkpoint Therapeutics worth $25K as of Q3 2019.
  • Checkpoint Therapeutics was a new BB&T Securities position in Q3 2019.
  • Checkpoint Therapeutics made up ﹤0.01% of BB&T Securities's portfolio in Q3 2019, its #1605 holding.
  • 37 funds tracked by Wall St. Rank held Checkpoint Therapeutics as of Q3 2019.

Based on BB&T Securities's 13F filing for Q3 2019, filed 30 Oct 2019.